Just Published
Original Research
Long-Term Outcomes of IV Ketamine and IN Esketamine in Treatment-Refractory Depression
July 30, 2025
The study results suggest that patients with treatment-resistant depression who are on maintenance treatment require less frequent treatments with IV ketamine compared to IN esketamine.
Original Research
Early Change in Depressive Symptom Severity with Naltrexone-Bupropion Combination and Its Association with Reduction in Methamphetamine Use: ADAPT-2 Trial
July 30, 2025
Improvement in depression accounted for approximately 25% of the treatment effect of naltrexone-bupropion on methamphetamine treatment response.
Recent Features
The Journal of Clinical Psychiatry
The Journal of Clinical Psychiatry is a leader in peer-reviewed articles on mental health topics for psychiatrists and medical professionals.
View JCP Articles
The Primary Care Companion for CNS Disorders
The Primary Care Companion for CNS Disorders seeks to advance the clinical expertise of primary care physicians and other health care professionals who treat patients with mental and neurologic illnesses.
View PCC Articles
Rounds in the General Hospital
FND in Active-Duty Military Personnel and Veterans
July 24, 2025
The most common presentations of functional neurologic disorder are functional seizures and functional movement disorders, including paresis. Other common manifestations are somatosensory or visual symptoms and speech disorders.
Recent CME Institute Activities
2025 Manuscript Peer Review for Physicians Postgraduate Press, Inc. (The Journal of Clinical Psychiatry | The Primary Care Companion for CNS Disorders)
Evaluating the Old and New in Alzheimer’s Disease: Today’s Options for Improving Diagnosis and Treatment
Alzheimer’s Disease: New Paths to Treatment
Staying Up to Date in Perinatal Depression: Pathophysiology and Treatment Research
Neuropsychiatric Complications of Parkinson’s Disease Psychosis
Assessing Progress in FSHD Treatment Options: Unraveling Challenges and Measuring Outcomes
